CD38 and neoplasm: In this study, we sought to discern the mechanistic impact of tumor-directed versus immune-directed effects of a CD38-targeted AttenukineTM, leveraging different immunocompromised and immunocompetent mouse models and various human or mouse CD38-directed AttenukineTM.